Pages that link to "Q36294009"

The following pages link to (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists. (Q36294009):

Displaying 48 items.

• Adenosine receptors as therapeutic targets (Q24632095) (← links)
• Translocation of arrestin induced by human A(3) adenosine receptor ligands in an engineered cell line: comparison with G protein-dependent pathways (Q24646643) (← links)
• Recent developments in adenosine receptor ligands and their potential as novel drugs (Q27687253) (← links)
• Emerging adenosine receptor agonists (Q28249111) (← links)
• Anticonvulsant activity of B2, an adenosine analog, on chemical convulsant-induced seizures (Q28534300) (← links)
• The imaging probe development center and the production of molecular imaging probes (Q33531824) (← links)
• The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells (Q33624360) (← links)
• Synthesis and biological evaluation of 2',4'- and 3',4'-bridged nucleoside analogues. (Q33992677) (← links)
• Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles (Q34002086) (← links)
• Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo. (Q34139908) (← links)
• Extended N(6) substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptor. (Q34152737) (← links)
• Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety (Q34313641) (← links)
• Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor (Q34540985) (← links)
• Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy (Q34765028) (← links)
• A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion (Q34999497) (← links)
• Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system. (Q35029175) (← links)
• Truncated (N)-Methanocarba Nucleosides as A(1) Adenosine Receptor Agonists and Partial Agonists: Overcoming Lack of a Recognition Element (Q35165684) (← links)
• A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats (Q35235736) (← links)
• Click modification in the N6 region of A3 adenosine receptor-selective carbocyclic nucleosides for dendrimeric tethering that preserves pharmacophore recognition. (Q35795478) (← links)
• Controlling murine and rat chronic pain through A3 adenosine receptor activation (Q35913037) (← links)
• Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions. (Q36021597) (← links)
• Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering (Q36146803) (← links)
• Purine receptors: GPCR structure and agonist design (Q36161738) (← links)
• Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands. (Q36171090) (← links)
• "Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists (Q36327179) (← links)
• Truncated Nucleosides as A(3) Adenosine Receptor Ligands: Combined 2-Arylethynyl and Bicyclohexane Substitutions (Q36377951) (← links)
• Action of nucleosides and nucleotides at 7 transmembrane-spanning receptors (Q36635966) (← links)
• Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists. (Q36725267) (← links)
• Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system (Q36996182) (← links)
• Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection (Q37003068) (← links)
• Synthesis of enantiomerically pure (S)-methanocarbaribo uracil nucleoside derivatives for use as antiviral agents and P2Y receptor ligands. (Q37180134) (← links)
• The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats (Q37180330) (← links)
• Synthesis and characterization of [76Br]-labeled high-affinity A3 adenosine receptor ligands for positron emission tomography (Q37268033) (← links)
• Synthesis and pharmacological characterization of [(125)I]MRS1898, a high-affinity, selective radioligand for the rat A(3) adenosine receptor. (Q37291606) (← links)
• Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain (Q37381136) (← links)
• Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species. (Q37461055) (← links)
• Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonists. (Q37637798) (← links)
• The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches (Q37957791) (← links)
• Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms (Q39133269) (← links)
• A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy (Q39418010) (← links)
• Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors (Q40781522) (← links)
• Synthesis of ethyl (1S,2R,3S,4S,5S)-2,3-O-(isopropylidene)-4-hydroxy-bicyclo[3.1.0]hexane-carboxylate from L-ribose: a versatile chiral synthon for preparation of adenosine and P2 receptor ligands. (Q46764720) (← links)
• A binding kinetics study of human adenosine A3 receptor agonists. (Q47804733) (← links)
• N6-Substituted 5'-N-Methylcarbamoyl-4'-selenoadenosines as Potent and Selective A3 Adenosine Receptor Agonists with Unusual Sugar Puckering and Nucleobase Orientation (Q48316436) (← links)
• Polypharmacology of conformationally locked methanocarba nucleosides. (Q53123581) (← links)
• Probing Structure-Activity Relationship in β-Arrestin2 Recruitment of Diversely Substituted Adenosine Derivatives (Q57185998) (← links)
• General Copper‐Catalyzed Transformations of Functional Groups from Arylboronic Acids in Water (Q83823817) (← links)
• Bioproduction of Benzylamine from Renewable Feedstocks via a Nine-Step Artificial Enzyme Cascade and Engineered Metabolic Pathways (Q88688948) (← links)